Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-02-11T07:28:23.523Z Has data issue: false hasContentIssue false

Lack of association between polymorphism -592A/C in the promoter region of IL10 gene and obsessive-compulsive disorder in Chinese Han population

Published online by Cambridge University Press:  24 June 2014

Shiguo Liu
Affiliation:
Shandong Provincial Key Laboratory of Metabolic Disease, The Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China
Yanhui Liu
Affiliation:
Department of Psychiatry, Medical College, Qingdao University, Qingdao 266021, China
Xinhua Zhang
Affiliation:
Department of Psychiatry, Medical College, Qingdao University, Qingdao 266021, China
Xu Ma
Affiliation:
Graduate School, Peking Union Medical College, Beijing, China
Rights & Permissions [Opens in a new window]

Abstract

Type
Comment & Critique
Copyright
Copyright © Cambridge University Press 2011

Obsessive-compulsive disorder (OCD) is a debilitating and chronic neuropsychiatric disorder with prevalence rates estimated to be as high as 0.13% in Mainland China (Reference Yang1), characterised by the presence of symptoms such as intrusive, unwanted thoughts and ideas that cause an increased amount of anxiety and intentional, repetitive behaviours (2). Evidence suggests that immune deficiency may be directly implicated in the pathophysiology of OCD, based on its symptomatic overlap with depression and schizophrenia and based on disturbances at the level of the hypothalamic-pituitary-adrenal axis (Reference Maes, Meltzer and Bosmans3,Reference Ravindran, Griffiths, Merali and Anisman4). As an important immunoregulatory cytokine and Th2 cell cytokine, interleukin 10 (IL10) is produced by lymphoid cells and exerts its functions by the inhibition of macrophage/monocyte and T-cell lymphocyte replication and the secretion of inflammatory cytokines, such as IL12, tumour necrosis factor (TNF)-α and IL8. Although IL10, located on chromosome 1q31–32, was previously reported to be linked to the development of multiple diseases, such as depressed mood (Reference Traks, Koido and Eller5) and schizophrenia (Reference Ozbey, Tug and Namli6) in genetic studies, the literature regarding the association between IL10 polymorphism and OCD remains poorly understood. To identify the association of -592A/C polymorphism in IL10 with susceptibility to OCD in a Chinese Han population, we recruited 181 OCD patients and 285 OCD-free controls from the Affiliated Hospital of Medical College, Qingdao University. Participants were comprised of 69 female and 112 male outpatients, aged between 10 and 70 years old, who were diagnosed with OCD fulfilling DSM-IV criteria, based on the Mini International Neuropsychiatric Interview (MINI) (Reference Sheehan, Lecrubier and Sheehan7).

Informed consent was obtained from all the subjects and the study was approved by the Medical Ethical Review Committee of the Affiliated Hospital of Medical College, Qingdao University. We analysed genetic distribution of allele and genotype of IL10 -592A/C by performing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Our results showed that there was no association between the genotypic frequencies and OCD (x 2 = 1.174, df = 2, p = 0.556) or between the allelic frequencies of IL10 -592A/C and OCD [x 2 = 0.286, df = 1, p = 0.593, odds ratio (OR) = 1.078, 95% confidence interval (CI) = 0.819–1.417].

Lack of significant difference in the clinical presentation was indicated between the two cohorts considering sex, clinical stage of onset, characteristic of symptom and clinical classification (DSM-IV) associated with OCD. In conclusion, there was a lack of association between OCD and IL10 -592A/C polymorphism in this Chinese Han population. The present study suggests that polymorphism at position -592 in IL10 does not confer susceptibility to OCD at least in this Chinese Han population. One main factor may have contributed to these negative findings, which is that only one polymorphism site (at position -592 of IL10) was examined. Further investigations are needed to confirm these findings.

References

1.Yang, DS.Behavior Medicine. China: Hunan Normal University Press, 1990;188.Google Scholar
2.American Psychiatric Association. Diagnostic and statistical manual of mental disorder, (4th edn. - text revision). Washington, DC: American Psychiatric Association, 2000.Google Scholar
3.Maes, M, Meltzer, HY, Bosmans, E.Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor and IL-1 beta and IL-6 concentrations. Neuropsychobiology 1994;30:5760.CrossRefGoogle ScholarPubMed
4.Ravindran, AV, Griffiths, J, Merali, Z, Anisman, H.Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J Affect Disord 1999;52:110.CrossRefGoogle ScholarPubMed
5.Traks, T, Koido, K, Eller, T et al. Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. BMC Med Genet 2008;9:111.CrossRefGoogle ScholarPubMed
6.Ozbey, U, Tug, E, Namli, M.Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey. World J Biol Psychiatry 2009;10(4 Pt 2):461468.CrossRefGoogle Scholar
7.Sheehan, DV, Lecrubier, Y, Sheehan, KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):2233.Google ScholarPubMed